EASY PARA PHARMACIE : revenue, balance sheet and financial ratios

EASY PARA PHARMACIE is a French company founded 18 years ago, specialized in the sector Vente à distance sur catalogue spécialisé. Based in NICE (06200), this company of category PME shows in 2022 a revenue of 40.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EASY PARA PHARMACIE (SIREN 499531457)
Indicator 2024 2023 2022 2021 2020 2019
Revenue N/C N/C 40 088 568 € N/C N/C 27 189 602 €
Net income 1 695 331 € 1 024 252 € -68 699 € 1 543 409 € 1 664 242 € 307 103 €
EBITDA N/C N/C 145 003 € N/C N/C 139 377 €
Net margin N/C N/C -0.2% N/C N/C 1.1%

Revenue and income statement

In 2024, EASY PARA PHARMACIE generates positive net income of 1.7 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 307 k€ -> 1.7 M€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 695 331 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 12%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

12.491%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

36.643%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

16.0%

Solvency indicators evolution
EASY PARA PHARMACIE

Sector positioning

Debt ratio
12.49 2024
2022
2023
2024
Q1: 0.0
Med: 3.84
Q3: 53.12
Average

In 2024, the debt ratio of EASY PARA PHARMACIE (12.49) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
36.64% 2024
2022
2023
2024
Q1: 0.0%
Med: 20.06%
Q3: 53.53%
Good +22 pts over 3 years

In 2024, the financial autonomy of EASY PARA PHARMACIE (36.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
9.07 years 2022
2022
Q1: -0.01 years
Med: 0.0 years
Q3: 0.47 years
Watch

In 2022, the repayment capacity of EASY PARA PHARMACIE (9.07) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 160.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

160.543

Liquidity indicators evolution
EASY PARA PHARMACIE

Sector positioning

Liquidity ratio
160.54 2024
2022
2023
2024
Q1: 109.05
Med: 201.82
Q3: 390.18
Average +8 pts over 3 years

In 2024, the liquidity ratio of EASY PARA PHARMACIE (160.54) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
40.51x 2022
2022
Q1: 0.0x
Med: 0.0x
Q3: 0.44x
Excellent

In 2022, the interest coverage of EASY PARA PHARMACIE (40.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
EASY PARA PHARMACIE

Positioning of EASY PARA PHARMACIE in its sector

Comparison with sector Vente à distance sur catalogue spécialisé

Valuation estimate

Based on 121 transactions of similar company sales (all years), the value of EASY PARA PHARMACIE is estimated at 6 370 281 € (range 2 078 336€ - 17 199 413€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
121 transactions
2078k€ 6370k€ 17199k€
6 370 281 € Range: 2 078 336€ - 17 199 413€
NAF 5 all-time

Valuation method used

Net Income Multiple
1 695 331 € × 3.8x = 6 370 281 €
Range: 2 078 336€ - 17 199 413€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 121 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Vente à distance sur catalogue spécialisé)

Compare EASY PARA PHARMACIE with other companies in the same sector:

Frequently asked questions about EASY PARA PHARMACIE

What is the revenue of EASY PARA PHARMACIE ?

The revenue of EASY PARA PHARMACIE in 2022 is 40.1 M€.

Is EASY PARA PHARMACIE profitable?

Yes, EASY PARA PHARMACIE generated a net profit of 1.7 M€ in 2024.

Where is the headquarters of EASY PARA PHARMACIE ?

The headquarters of EASY PARA PHARMACIE is located in NICE (06200), in the department Alpes-Maritimes.

Where to find the tax return of EASY PARA PHARMACIE ?

The tax return of EASY PARA PHARMACIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EASY PARA PHARMACIE operate?

EASY PARA PHARMACIE operates in the sector Vente à distance sur catalogue spécialisé (NAF code 47.91B). See the 'Sector positioning' section above to compare the company with its competitors.